Blogs

Latest Blogs

GMP Grade Ligand Binding and Potency Assays – Frequently Asked Questions

Good Manufacturing Practice ligand binding and potency assays are essential for ensuring the quality, safety, and regulatory compliance of biopharmaceutical products.…
11 Sep, 2025 |  Blogs
Video

Quantitative Analysis of Oligonucleotides: An out of the box LC-MS/MS approach

Oligonucleotide therapeutics have revolutionised the field of medicine over the last decade due to their potential for treating a broad…
05 Mar, 2025 |  Blogs
Video

The Next Frontier for CAR T-Cell Therapy: Shifting Gears to Autoimmune Conditions

CAR T-cell therapy has transformed cancer treatment, offering new hope for patients with aggressive B cell malignancies like acute lymphoblastic…
18 Feb, 2025 |  Blogs
Video

Identifying biomarkers of success: Integrated bioanalysis for glioblastoma CAR-T cell clinical trials

Glioblastoma remains one of the most aggressive and treatment-resistant cancers. Standard therapies often fail, leaving patients with limited options.…
18 Oct, 2024 |  Blogs
Video

Allogeneic CAR T cell therapies: A major step forward

In a groundbreaking clinical trial, three individuals suffering from severe autoimmune diseases have entered remission following a novel CAR T…
09 Oct, 2024 |  Blogs
Video

A controlled detonation: Targeted antibody drug conjugates (ADCs) for oncology

Are antibody-drug conjugates (ADCs), principally comprised of an antibody, a cytotoxic payload and a linker, the next therapeutic modality of…
17 Sep, 2024 |  Blogs
Video

The mpox outbreak: Variants, transmission and the boost for vaccine manufacturers

Following Covid-19, the world is collectively on high alert for anything that could indicate another pandemic. What do we know…
05 Sep, 2024 |  Blogs

Quick Links

Talk to our Biomarker Experts